- Application deadline
- 15 Nov 2026
- Stipend / salary
- ₹500
- Qualifications mentioned
- PhD, Master's (MSc/MTech/MPharm), Bachelor's (BSc/BTech/BPharm), NET/GATE qualified
- Posted
- 16 Oct 2026 · Government
About this position
Ref. No: NIBMG/ACADEMIC/PHD PROG/ADVT/2026-27/231 Date: 14-10-2026 INFORMATION FOR STUDENTS INTERESTED TO PURSUE DOCTORAL RESEARCH Applications are invited from suitable candidates to pursue doctoral research at NIBMG. The selected students are expected to work on human diseases with emphasis on gaining genomics and biological insights into disease mechanisms using clinical samples and appropriate models, both in silico, in-vitro and in vivo. NIBMG is equipped with state-of-the- art technologies which include single-cell sequencing, spatial transcriptomics and next generation sequencing platforms, robotics platforms, high-end computational and bioinformatics facility, cell and molecular biology facilities, genetic engineering including cutting-edge CRISPR-Cas genome editing laboratories. High-end equipments including imaging base flow cytomers, confocal microscopes with deep-tissue imaging capability, BSL3 facility, bacteriology and radioactivity labs, zebrafish facility, proteomics, metabolomics, experimental animal facility and microbiome facilities are available. Broad Research Areas • Chronic and Metabolic Diseases: Host-Microbiome interactions in Complex Diseases, Metagenome Wide Association Study (MWAS), Antimicrobial Resistance MASLD. Human Disease Models, Cardiopulmonary Disorder Phenotypes and Translation studies • Infectious and Immune Disorders: Tuberculosis, Host pathogen interaction, Congenital Heart disease, Autoimmune disease and novel immunotherapeutic approaches. • Cell and Molecular Mechanisms: Placenta biology. Gene regulation, preterm birth, placenta, single-cell transcriptomics, genomics • Computational and Systems Biology: Statistical Genomics, Shared Genomic Architecture of Complex Diseases, Functional Mechanisms of GWAS variants • Experimental Platforms: In vitro, in vivo, and in silico models; translational studies with mechanistic and therapeutic relevance. Fellowship: Admissible as per Govt. of India rules as provided by respective funding agency.